1. Guest Editorial: Systemic human antisense therapy begins;Bayever;Antisense Res Dev,1992
2. p53 mutation is a common genetic event in ovarian carcinoma;Milner;Cancer Res,1993
3. Widespread p53 overexpression in human malignant tumors;Porter;Am J Pathol,1992
4. The p53 Tumor Suppressor Gene and Product, in Cancer Surveys: Tumor Suppressor Genes, the Cell Cycle and Cancer;Levine,1992
5. p53 function and dysfunction;Vogelstein;Cell,1992